AR and VR in Interventional Neuroradiology Market
Report ID: SQMIG35G2372
Report ID: SQMIG35G2372
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35G2372 |
Region:
Global |
Published Date: February, 2026
Pages:
157
|Tables:
151
|Figures:
78
Global AR And VR in Interventional Neuroradiology Market size was valued at USD 2.8 Billion in 2024 and is poised to grow from USD 3.36 Billion in 2025 to USD 14.56 Billion by 2033, growing at a CAGR of 20.1% during the forecast period (2026-2033).
The global AR and VR in interventional neuroradiology market growth exhibits because patients increasingly request neurovascular treatments which require less surgical intervention. The technology enables surgeons to view complex vascular structures in three-dimensional space which improves their navigation abilities while reducing surgical risks. The combination of immersive visualization technology with angiography and navigation systems has transformed surgical planning methods which surgeons use to operate their procedures and teach other surgeons.
Hospitals began utilizing AR overlays to perform aneurysm coiling procedures and VR simulations to treat stroke patients. GE HealthCare and MediView introduced OmnifyXR in June 2024 as the first clinical heads-up AR system which enables users to view both holographic human anatomy and real-time medical imaging. The real world attained a major milestone through this agreement. The technology improved display transitions while it made process operations more efficient.
The global AR and VR in interventional neuroradiology industry experiences growth because digital healthcare investments increase and training requirements rise and developed countries receive reimbursement support for their healthcare systems. Software-as-a-service models together with outcome-based payment systems increase the probability of their implementation. The smaller healthcare facilities encounter difficulties because they face high construction costs and they struggle with system integration issues.
How are AR and VR enhancing procedural accuracy in the interventional neuroradiology market?
Augmented reality and virtual reality enhance procedural accuracy in interventional neuroradiology by delivering real-time three-dimensional visualization, image fusion, and immersive rehearsal. The AR system uses real-time imaging to show virtual anatomical structures, which enables doctors to navigate catheters with improved spatial accuracy. Virtual reality technology delivers realistic medical training environments which help healthcare workers train their medical skills while decreasing their mental workload and improving their eye-hand coordination abilities. The global AR and VR interventional neuroradiology market outlook shows a trend towards systems which combine these technologies with angiography systems to support heads up display and distance monitoring and speed up decision processes during medical procedures. Holographic displays enable catheter guidance through practical applications while providing immersive rehearsal training for complex aneurysm embolization procedures which enhance operator confidence and performance consistency.
The OmnifyXR AR interventional suite is a great example because it was the full operating system for the North Star Vascular and Interventional Center in Minneapolis, Minnesota, in 2024. The device has a heads-up display system that shows live fluoroscopic images, holographic 3D anatomical views, and multiple imaging streams. The system enables doctors to see detailed vascular structures during catheter navigation and embolization procedures, which leads to fewer screen changes and better operational efficiency.
Market snapshot - 2026-2033
Global Market Size
USD 2.8 Billion
Largest Segment
Hardware
Fastest Growth
Software-as-a-Service (SaaS)
Growth Rate
20.1% CAGR
To get more insights on this market click here to Request a Free Sample Report
The global AR and VR in interventional neuroradiology market is segmented based on component, pathology type, technology type, application, end user, and region. By component, the market is classified into hardware, Software-as-a-Service (SaaS), and integration services. Based on pathology type, it includes intracranial aneurysms, arteriovenous malformations (AVM), acute ischemic stroke, carotid artery disease, spinal interventions, and other conditions. By technology type, the market is segmented into augmented reality (AR), virtual reality (VR), mixed reality (MR), and cinematic rendering. In terms of application, it covers intraoperative navigation, surgical simulation, remote proctoring, patient engagement, and other uses. Based on end user, the market serves academic medical centers, teaching hospitals, ambulatory surgery centers (ASCs), and medical device research and development institutions. Regionally, the market is analyzed across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
As per the global AR and VR interventional neuroradiology market analysis, the hardware segment emerged as the most important component because it enabled doctors to observe procedures during live operations. High-fidelity displays, tracking systems, sensors, and imaging interfaces constitute essential elements for precise AR/VR guidance in complex neurovascular conditions. The OmnifyXR AR suite which was implemented in 2024 serves as a real-world example. The system combined holographic overlays with live fluoroscopy to boost worker efficiency and confidence during aneurysm coiling and catheter navigation procedures.
However, the SaaS subsegment is expected to experience rapid growth during the forecast period because hospitals adopt cloud-based AR/VR technologies for remote access and analytics and simulation. SaaS methods enable continuous improvements while saving initial expenses through their ability to enable remote exam proctoring and collaborative work. Trainers now need training programs which can adapt to their needs together with software ecosystems which need to function with each other. The growing use of SaaS solutions for procedure planning and physician education will become a more effective approach to medical education.
According to the global AR and VR interventional neuroradiology market forecast, the primary surgical challenge for surgeons arises from their need to navigate through intracranial aneurysms, which represent the most prevalent surgical pathology. AR/VR systems create a 3D visual representation of an aneurysm's shape together with its surrounding blood vessels, which enables precise catheter guidance. The application of AR overlays during aneurysm coiling and flow diversion procedures proved to improve patient outcomes while decreasing operation time at several major neurocenters.
Whereas the acute ischemic stroke sub-segment is anticipated to have the highest AR and VR in interventional neuroradiology market share because immersive technologies now enable medical professionals to visualize thrombus and practice treatment procedures. Clinicians can use VR simulation together with AR live imaging to develop better thrombectomy routes while reducing their time spent navigating medical devices. The increasing number of strokes and the necessity for prompt intervention will lead to the introduction of AR/VR tools in stroke care regimens.
To get detailed segments analysis, Request a Free Sample Report
As per the AR and VR interventional neuroradiology market regional forecast, North America leads due to a confluence of mature healthcare infrastructure, concentration of leading medical technology firms, and a clinical community that embraces innovation. High acuity neuro centers and interdisciplinary teams facilitate early clinical validation and iterative product refinement. A supportive reimbursement environment and established training programs enable widespread deployment in tertiary hospitals and academic centers. Robust private investment and venture support accelerate commercialization and scale up of immersive visualization and guidance platforms.
The regulatory frameworks which combine stringent requirements with expected results create an environment that manufacturers use to determine their market entry strategies. The three parties that include device manufacturers and system integrators and clinical researchers work together to build solutions which meet workflow requirements and create a positive cycle which drives technology adoption and ongoing enhancements. The ecosystem generates authenticated clinical use cases which help organizations maintain their market dominance while bringing international interest to their operations.
The U.S. AR and VR in interventional neuroradiology sector grows by establishing a comprehensive system of neuro centers and medtech companies and financial resources which enable quick development of new medical technologies through their transition to clinical practice. Academic hospitals which belong to the early clinical adopter group work with vendors to verify system performance while creating educational materials for training purposes. The combination of a sympathetic clinical community and reimbursement policies creates a foundation for commercial product introduction, while the vendor ecosystem delivers deployment solutions which fit with intricate imaging workflows used during procedures.
The AR and VR in interventional neuroradiology market in Canada shows focused adoption in academic health centers and specialty hospitals where collaborative research informs clinical validation. National health systems promote their core objectives by creating programs which provide remote access to tele-mentoring and remote procedural guidance. Universities and hospitals together with domestic vendors create partnerships which establish practical solutions based on referral patterns, which include training programs for clinicians and compatibility with current imaging systems and cost analysis prior to extended deployment.
European countries have rapidly grown because their healthcare systems work together with their medical device manufacturing strengths and their active research networks which support clinical applications. The neurointerventional clinical excellence centers function as test sites which assess immersive guidance and simulation technologies. Public and private funding mechanisms support collaborations between industry and academic hospitals to accelerate both clinical validation and clinician training. The market benefits from a diverse ecosystem where national champions integrate local clinical needs with global technology partners to create scalable deployments which match different care pathways and procurement models used throughout the region.
The AR and VR in interventional neuroradiology market in Germany pairs a strong medical technology manufacturing base with high concentration of specialized neuro centers that undertake rigorous clinical evaluation. Local device developers and collaborative supply chains enable hospitals to use their products together with their imaging systems. The tertiary centers proceed with implementing their systems because the procurement committees and reimbursement frameworks officially acknowledge the clinical advantages which have been validated. The clinical societies and training academies support adoption through their established educational programs and sharing of experiences which occur between multiple centers.
The AR and VR in interventional neuroradiology market in the UK benefits from innovation hubs, a tertiary neuro center network, and collaborative NHS initiatives that favor clinical evaluation and pathway adoption. Academic hospitals partner with industry to pilot immersive guidance and simulation for procedural training and workflow testing. Public and private institutions make procurement decisions faster because they focus on both cost effectiveness and standardized outcomes, which clinician champions and training networks help to spread across the medical field.
The AR and VR in interventional neuroradiology market in France shows emerging adoption led by strong academic research clusters and hospitals that prioritize clinical innovation. The research institutes and industry partners work together on translational projects which create immersive guidance systems that fit local clinical pathways. Reimbursement and procurement decisions proceed with caution, yet they become more accepting after pilot studies show how they improve workflow efficiency. The program focuses on clinician training while it builds interoperability with national imaging standards and develops centers of excellence throughout the region.
Asia Pacific region achieves its advancement through its robust manufacturing of electronic devices together with its development of neurointerventional medical skills and its government programs which support medical technology adoption. Vendors from regional areas are using immersive visualization and simulation platforms for their local operational needs and their existing imaging systems. Hospitals use their resources to create training programs and operational centers which provide students with complete learning experiences of medical procedures. The combination of technology companies with academic institutions and healthcare networks enables faster solution validation and adaptation to local contexts. The region establishes greater global recognition through its strategic export activities and its participation in international clinical research. The result is a progressively mature market where practical implementation experience, local manufacturing scale, and supportive policy environments converge to create viable alternatives to legacy offerings and to attract global partnerships.
Advanced imaging systems establish the Japanese AR and VR in interventional neuroradiology market. The Japanese market used in interventional neuroradiology combines advanced imaging systems with domestic device development and hospitals that prioritize thorough clinical evaluation. Leading neurosurgical centers use immersive visualization together with their advanced imaging systems and robotic technologies to conduct detailed studies of workflow processes. The combination of strict regulatory standards together with a clinical evidence-based approach leads to controlled implementation of clinical evidence-based solutions which specialists develop through their relationships with international vendors and academic partners.
The AR and VR in interventional neuroradiology market in South Korea leverages electronics industry strength, domestic startups and national research institutes, and hospital networks that pilot advanced imaging adjuncts. Public private partnerships and industrial policy encourage commercialization and development of immersive procedural systems. Tertiary hospitals emphasize integration with existing imaging platforms and procedural workflows, while clinician led pilots validate utility. Collaboration between technology firms and clinical champions accelerates adoption across leading centres.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Clinical Adoption Of Immersive Visualization
Clinical acceptance of immersive visualization tools in interventional neuroradiology has increased clinician confidence in planning and executing complex procedures, which drives procurement and integration. Hospitals and specialists perceive enhanced visualization as enabling more precise targeting and lower procedural uncertainty which drives their investment in additional imaging systems and their training programs. The clinical teams with their ongoing use of these tools in daily operations create institutional demand for AR and VR systems which can work with their current AR and VR systems. The demand for these systems leads to development of custom solutions by vendors who create products based on existing operational patterns.
Technological Advances In Visualization Platforms
The ongoing development of augmented reality and virtual reality technologies which includes their hardware upgrades and software enhancements results in better image quality and lower latency times and improved user-friendly design for angiography systems, making these technologies suitable for regular use in neuroradiology. The development of more user-friendly imaging interfaces with improved imaging system compatibility by developers allows clinicians to work more efficiently while increasing their ability to use medical imaging systems. There is an increase in investment value for purchasing stakeholders because platform development leads to advanced capabilities which become easier to use in procedural settings, thus creating a competitive environment that accelerates vendors to develop features which meet specific interventional neuroradiology requirements.
High Initial Costs and Integration Burden
The hospital procurement process and market growth for AR and VR systems face limitations because hospitals must first spend large amounts to purchase these technologies and then they need to pay additional costs for their deployment into current imaging systems and IT networks. The budget holders together with the procurement committees must evaluate three factors which include how difficult the system will be implemented and how much training staff members will need and how much ongoing maintenance work will be required against the clinical advantages which they perceive. The market development process experiences slowdowns because healthcare organizations implement new technologies only after they acquire financial resources dedicated to research activities.
Regulatory Uncertainty In Clinical Workflows
Unclear or evolving regulatory pathways for therapeutic use of immersive technologies in procedural settings introduce uncertainty that restrains investment and deployment. Stakeholders postpone their adoption decisions because they find the requirements unclear while they wait for better understanding thus extending the validation process because they should have used established traditional technologies. The AR and VR interventional neuroradiology market penetration process experiences slower progress because of this hesitancy which also decreases the financial benefits that support fast development of interventional neuroradiology innovations.
Request Free Customization of this report to help us to meet your business objectives.
Competition is driven by regulatory clearances, clinical validation and OR integration demands, forcing firms to pursue M&A, strategic partnerships and rapid product innovation. Examples include Realize Medical’s VR planning FDA clearance and hardware partnerships, Scopis’ integration with Microsoft HoloLens for holographic navigation, and Xironetic’s FDA cleared IntraOpVSP backed by clinical publications supporting adoption.
Realize Medical: Realize Medical was created in 2019 and focuses on offering Elucis, a virtual reality platform that lets doctors swiftly construct 3D models of patients' bodies and plan surgeries in a way that makes them feel like they are there. The software lets people from different areas look at situations together and practice before surgery. The company recently gained FDA approval for Elucis and it expanded its partnerships with hardware and workflow vendors to establish VR planning as a standard clinical procedure. The data demonstrates that hospitals are increasing their usage of the technology while clinical applications are shifting toward more teamwork between medical professionals.
Xironetic: Xironetic was created in 2021 with the purpose of inventing IntraOpVSP, an augmented reality surgical navigation system that shows patient CT and MRI data as 3D holograms to aid surgeons navigate during cranial, neurovascular, and craniofacial surgeries. The business just gained FDA approval for IntraOpVSP and presented clinical evidence indicating how it can aid with craniofacial surgery. The organization has established clinical research initiatives in neurosurgery to study both operating room utilization and its effects on patient outcomes.
Augmedics received FDA 510k approval for its X2 surgical AR headset in November 2025, which the company presented as a next generation product that offers double the field of view, better image quality, detachable surgical headlight, and design which improves surgeon comfort and intraoperative visualization to support the company's expansion of AR navigation for spine and neuro procedures.
Brainlab received FDA 510k approval which enabled them to launch their Spine Mixed Reality Navigation system in September 2025. This system enables surgeons to see optical navigation through mixed reality which shows them the surgical guidance during spinal and neurosurgery procedures. The solution provides ergonomic visualization for pedicle screw placement which helps surgeons work more efficiently while adopting mixed reality technology in their minimally invasive spinal and neurosurgery procedures.
Augmedics reported completion of its 10,000th augmented reality spine surgery in April 2025 and initiated commercial rollout of CT to fluoro registration in April 2025, highlighting company leadership in surgical AR, expanding access to navigation without intraoperative 3D imaging, and reinforcing xvision’s open platform strategy to support broader clinical use across spine and adjacent neuro specialties.
Immersive Training and Simulation: One of the key AR and VR in interventional neuroradiology industry trends include immersive training and simulation. Hospitals now use augmented and virtual reality technology to train clinicians through authentic practice sessions which include anatomy demonstrations and secure team training. The systems enable uniform skill assessment while helping trainees to develop skills which they will need in their upcoming professional work. Personalized learning pathways show positive effects on operator readiness through case library connections and patient-specific model integration. The need for certified simulation-based training systems which can work with different academic programs and medical practice environments will increase when institutions start using simulation-based credentialing systems.
Remote Procedural Collaboration: Remote collaboration tools now enable expert neuroradiologists to deliver remote expert guidance for complex procedures through their capacity to use immersive overlays and live imaging synchronization and shared spatial annotations. The system enables faster decision making because it provides access to subspecialty expertise from multiple locations and improves multidisciplinary coordination during medical procedures. Health systems and vendors currently focus on developing secure low latency platforms which operate with imaging networks and enable consistent communication through predetermined protocols. As clinical teams embrace tele mentoring workflows, cross site knowledge transfer and uptake of advanced techniques will foster broader equitable access.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the AR and VR in interventional neuroradiology market experiences main growth because medical procedures need improved accuracy and fewer complications. The growing use of immersive technology together with its better imaging and navigation and AI capabilities enables this development. The system uses these functions to deliver faster treatments which reduce radiation exposure and produce better treatment results. The system requires expensive initial investments and complex system installation which makes it difficult for small healthcare organizations to implement the technology. North America maintains its status as the leading region because it possesses an advanced healthcare system numerous medical technology companies and effective reimbursement policies. The AR/VR guiding system depends on hardware components which include high-fidelity screens and tracking systems and imaging interfaces as the primary methods of operation. The market keeps expanding because all these elements work together to create a healthcare system which develops safe medical practices and innovative clinical procedures.
| Report Metric | Details |
|---|---|
| Market size value in Interventional | USD 2.8 Billion |
| Market size value in 2033 | USD 14.56 Billion |
| Growth Rate | 20.1% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the AR and VR in Interventional Neuroradiology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the AR and VR in Interventional Neuroradiology Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the AR and VR in Interventional Neuroradiology Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the AR and VR in Interventional Neuroradiology Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Ar And Vr In Interventional Neuroradiology Market size was valued at USD 2.8 Billion in 2024 and is poised to grow from USD 3.36 Billion in 2025 to USD 14.56 Billion by 2033, growing at a CAGR of 20.1% during the forecast period (2026-2033).
Competition is driven by regulatory clearances, clinical validation and OR integration demands, forcing firms to pursue M&A, strategic partnerships and rapid product innovation. Examples include Realize Medical’s VR planning FDA clearance and hardware partnerships, Scopis’ integration with Microsoft HoloLens for holographic navigation, and Xironetic’s FDA cleared IntraOpVSP backed by clinical publications supporting adoption. 'Surgical Theater', 'ImmersiveTouch', 'Augmedics', 'Proprio', 'EchoPixel', 'Osso VR', 'Medivis', 'Brainlab', 'MediView', 'Novarad', 'FundamentalVR', 'Vicarious Surgical', 'Vuzix', 'Magic Leap', 'HoloSurgical', 'XRHealth', 'SentiAR', 'MindMaze', 'PrecisionOS', 'Virti'
Clinical acceptance of immersive visualization tools in interventional neuroradiology has increased clinician confidence in planning and executing complex procedures, which drives procurement and integration. Hospitals and specialists perceive enhanced visualization as enabling more precise targeting and lower procedural uncertainty, encouraging investment in complementary imaging platforms and training programs. As clinical teams incorporate these tools into routine workflows and training curricula, institutional demand grows for interoperable AR and VR systems that align with existing practices, fueling market adoption and vendor development of tailored solutions.
Why does North America Dominate the Global AR and VR in Interventional Neuroradiology Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
